Since our last update in December, the UK and the EU have officially agreed on a Brexit deal. The agreement has brought with it a multitude of legislative changes across various areas of UK law. In support of understanding...more
2/11/2021
/ Antitrust Provisions ,
Competition ,
Cybersecurity ,
EU ,
General Data Protection Regulation (GDPR) ,
Life Sciences ,
Merger Controls ,
Popular ,
UK ,
UK Brexit ,
UK Competition and Markets Authority (CMA)
On 31 January 2020, the UK left the European Union and entered a transition period that is due to end at 11:00 pm GMT on 31 December 2020. At this point, it is still uncertain whether a new EU/UK deal will be reached. To...more
12/4/2020
/ Antitrust Provisions ,
Competition ,
Contract Drafting ,
Court of Justice of the European Union (CJEU) ,
Cybersecurity ,
Data Privacy ,
Employer Liability Issues ,
EU ,
EU Single Market ,
European Economic Area (EEA) ,
Free Trade Agreements ,
General Data Protection Regulation (GDPR) ,
Insurance Industry ,
Life Sciences ,
Merger Controls ,
Patents ,
Popular ,
Tax Planning ,
Trademarks ,
UK ,
UK Brexit ,
UK Competition and Markets Authority (CMA)
The result of the UK referendum to leave the European Union came as a surprise to many and it has caused significant disquiet in the world. In this note we aim to address the key concerns of our life sciences clients...more
Last week Europe's highest court, the Court of Justice of the European Union (CJEEA) declared the Safe Harbor framework invalid. Many life sciences and biotech companies relied on Safe Harbor to legitimise transfers of...more
10/13/2015
/ Best Practices ,
Binding Corporate Rules ,
Data Protection Authority ,
EU ,
EU Data Protection Laws ,
European Commission ,
European Court of Justice (ECJ) ,
European Economic Area (EEA) ,
International Data Transfers ,
Model Contracts ,
Safe Harbors ,
US-EU Safe Harbor Framework